66
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Does premedication with dexmedetomidine provide perioperative hemodynamic stability in hypertensive patients?

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Perioperative hemodynamic fluctuations are seen more often in hypertensive patients than in normotensive patients. The purpose of our study was to investigate the perioperative hemodynamic effects of dexmedetomidine and midazolam used for premedication in hypertensive patients relative to each other and in comparison to normotensive patients.

          Methods

          One-hundred-forty female, normotensive or hypertensive patients undergoing myomectomies or hysterectomies. They were randomly enrolled into the subgroups: Group ND (normotensive-dexmedetomidine); Group HD (hypertensive-dexmedetomine); Group NM (normotensive-midazolam); Group HM (hypertensive- midazolam). Dexmedetomidine was administered at a concentration of 0.5 μg.kg −1, and midazolam was administered at a concentration of 0.025 μg.kg −1 via intravenous (IV) infusion before the induction of anaesthesia. Haemodynamic parameters were recorded at several times (T beginning, T preop5 min, T preop 10 min, T induction, T intubation, T intubation 5 min, T initial surgery, T surgery 15 min, T surgery 30 min, T extubation, T extubation 5 min). Propofol amount for induction, time between induction and initial surgery, demand of antihypertensive therapy, rescue atropine were recorded. Quantitative clinical and demographic characteristics were compared using One Way ANOVA. The values were compared using One-way Analysis of Variance. Additionally periodic variations were examined by One way Repeated Measures Analysis of Variance for groups separately.

          Results

          SBP was significantly different between normotensive and hypertensive groups at the following time points: T preop 5 min, T preop 10 min, T induction, T intubation , T intubation 5 min and T initial surgery. MBP was significantly different in the hypertensive groups at T induction, T intubation, T intubation 5 min, T initial surgery, T surgery 15 min, T surgery 30 min, T extubation and T extubation 5 min. The perioperative requirements for antihypertensive drugs were significantly higher in Group HM.

          Conclusion

          In the hypertensive patients, dexmedetomidine premedication provides better hemodynamic stability compared with midazolam, and because it decreases the antihypertensive requirements, its use might be beneficial.

          Trial registration

          Trial registration: Clinicaltrials.gov identifier: NCT02058485.

          Related collections

          Most cited references28

          • Record: found
          • Abstract: not found
          • Article: not found

          ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Intraoperative infusion of dexmedetomidine reduces perioperative analgesic requirements.

            This prospective, randomized, double-blind study was designed to assess whether intraoperative infusion of dexmedetomidine provides effective postoperative analgesia. Postoperative pain scores and morphine consumption were compared in a treated group and a placebo group, both of which received patient-controlled morphine after total abdominal hysterectomy. Fifty women were randomly assigned to two groups. Group D (n = 25) received a loading dose of dexmedetomidine 1 mug.kg(-1) iv during induction of anesthesia, followed by a continuous infusion at a rate of 0.5 mug.kg(-1).hr(-1) throughout the operation. Group P (n = 25) received a volume-matched bolus and infusion of placebo (0.9% saline). For each case, heart rate, peripheral oxygen saturation, and systolic and diastolic blood pressure were recorded intraoperatively and for 48 hr postoperatively. Patients used a patient-controlled analgesia device to receive bolus doses of morphine after surgery. Total morphine consumption, pain scores, and sedation scores were recorded for the first 48 hr (two hours in the postanesthesia care unit and 46 hr on the ward). The groups were similar with respect to mean times to extubation of the trachea. Pain and sedation scores were also similar between groups at all corresponding times throughout the 48-hr period of observation. Group D patients consumed significantly less morphine in the postanesthesia care unit and on the ward (P < 0.05 and P < 0.01, respectively). Fewer patients in Group D experienced itching or nausea/vomiting (P < 0.05). Continuous iv dexmedetomidine during abdominal surgery provides effective postoperative analgesia, and reduces postoperative morphine requirements without increasing the incidence of side effects.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Dexmedetomidine in anaesthesia.

              The development of dexmedetomidine, a potent and highly selective alpha2-adrenoceptor agonist, has created new interest in the use of alpha2-adrenoceptor agonists, and has led to its evaluation in various yet non-approved perioperative settings. The current review focuses on the usefulness of dexmedetomidine in anaesthesia practice. Recently acquired knowledge and experience with dexmedetomidine in perioperative use will be presented and discussed in the context of known pharmacological properties. Dexmedetomidine offers beneficial pharmacological properties, providing dose-dependent sedation, analgesia, sympatholysis and anxiolysis without relevant respiratory depression. The side-effects are predictable from the pharmacological profile of (2-adrenoceptor agonists. In particular, the unique sedative properties of dexmedetomidine resulted in several interesting applications in anaesthesia practice, promising benefits in the perioperative use of this compound. However, dexmedetomidine was approved for sedation in the intensive care unit in the USA in 1999, and administration in anaesthesia practice remains an 'off-label' use. Further studies are needed to establish the role of dexmedetomidine in the perioperative period.
                Bookmark

                Author and article information

                Contributors
                gysezen@hotmail.com
                demiraran@gmail.com
                yilknur74@hotmail.com
                ibrahimkaragoz@duzce.edu.tr
                abdulkadiriskender@duzce.edu.tr
                handanankarali@duzce.edu.tr
                drozlemersoy@gmail.com
                onurozlu@duzce.edu.tr
                Journal
                BMC Anesthesiol
                BMC Anesthesiol
                BMC Anesthesiology
                BioMed Central (London )
                1471-2253
                10 December 2014
                10 December 2014
                2014
                : 14
                : 1
                : 113
                Affiliations
                [ ]Department of Anesthesiology and Reanimation, Duzce University Faculty of Medicine, Duzce, Turkey
                [ ]Department of Biostatistics, Duzce University Faculty of Medicine, Duzce, Turkey
                Article
                325
                10.1186/1471-2253-14-113
                4279802
                25550680
                3110f107-b308-4cfb-ac9e-bfb3c15e2ffd
                © Sezen et al.; licensee BioMed Central. 2014

                This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 11 September 2014
                : 25 November 2014
                Categories
                Research Article
                Custom metadata
                © The Author(s) 2014

                Anesthesiology & Pain management
                dexmedetomidine,midazolam,premedication,hypertension
                Anesthesiology & Pain management
                dexmedetomidine, midazolam, premedication, hypertension

                Comments

                Comment on this article